Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
7,969
-216
-3% -$46.5K 0.77% 50
2026
Q1
$1.78M Hold
8,185
0.75% 52
2025
Q4
$1.87M Sell
8,185
-133
-2% -$30.3K 0.72% 48
2025
Q3
$1.93M Hold
8,318
0.71% 50
2025
Q2
$1.54M Hold
8,318
0.6% 53
2025
Q1
$1.74M Hold
8,318
0.48% 55
2024
Q4
$1.47M Buy
+8,318
New +$1.53M 0.41% 56

Other funds holding ABBV

InvesTrust's ABBV Position: Q2 2026 in Review

InvesTrust reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $46.5K and leaving 7,969 shares worth $2.01M. The position accounts for 0.77% of the portfolio, ranked #50.

InvesTrust first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • InvesTrust held 7,969 shares of AbbVie worth $2.01M as of Q2 2026.
  • InvesTrust sold 216 AbbVie shares in Q2 2026, an estimated $46.5K.
  • AbbVie made up 0.77% of InvesTrust's portfolio in Q2 2026, its #50 holding.
  • InvesTrust first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on InvesTrust's 13F filing for Q2 2026, filed 14 Jul 2026.